GRP
SUPN icon

Global Retirement Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Global Retirement Partners’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$69.8K Buy
1,404
+1,182
+532% +$57.5K ﹤0.01% 2142
2025
Q3 		$10.6K Sell
222
-47
-17% -$1.89K ﹤0.01% 2678
2025
Q2 		$8.48K Buy
+269
New +$8.62K ﹤0.01% 2683
2024
Q4 		$2.39K Sell
66
-20
-23% -$704 ﹤0.01% 3002
2024
Q3 		$2.68K Hold
86
– – ﹤0.01% 2836
2024
Q2 		$2.3K Buy
86
+67
+353% +$1.94K ﹤0.01% 2918
2024
Q1 		$648 Hold
19
– – ﹤0.01% 3075
2023
Q4 		$541 Buy
+19
New +$504 ﹤0.01% 3061
2019
Q4 		– Sell
-500
Closed -$14K – 1696
2019
Q3 		$14K Hold
500
– – ﹤0.01% 1036
2019
Q2 		$17K Buy
+500
New +$17.1K ﹤0.01% 972

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's SUPN Position: Q4 2025 in Review

Global Retirement Partners increased its Supernus Pharmaceuticals (SUPN) stake by 532% in Q4 2025, buying an estimated $57.5K and bringing the position to 1,404 shares worth $69.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

Global Retirement Partners first reported a position in SUPN in Q2 2019 and has held it in 10 quarters since. 333 funds tracked by Wall St. Rank hold SUPN as of Q4 2025.

  • Global Retirement Partners held 1,404 shares of Supernus Pharmaceuticals worth $69.8K as of Q4 2025.
  • Global Retirement Partners bought 1,182 Supernus Pharmaceuticals shares in Q4 2025, an estimated $57.5K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2142 holding.
  • Global Retirement Partners first reported a position in Supernus Pharmaceuticals in Q2 2019 and has held it in 10 quarters since.
  • 333 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.